Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child.
Pediatr Dermatol
; 37(4): 754-755, 2020 Jul.
Article
in En
| MEDLINE
| ID: mdl-32255214
ABSTRACT
Segmental vitiligo often presents in childhood and tends to be more recalcitrant to therapy than generalized vitiligo. Recently, Janus kinase inhibitors have emerged as a promising treatment option, with some reports suggesting that concomitant ultraviolet light exposure may enhance therapeutic response. Here, we present a child with segmental vitiligo who responded rapidly and completely to treatment with tofacitinib cream plus phototherapy.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ultraviolet Therapy
/
Vitiligo
Limits:
Child
/
Humans
Language:
En
Journal:
Pediatr Dermatol
Year:
2020
Document type:
Article